SCHEMBL19170606

SCHEMBL19170606

Cc1ccccc1S(=O)(=O)N(C)CC1CNC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.45
▸ HTR2A P28223 1/20 0.45
▸ HTR2B P41595 1/20 0.39
▸ NPY5R Q15761 2/20 0.38
▸ CASP6 P55212 1/20 0.36
▸ KMT2A Q03164 2/20 0.35
▸ HCRTR2 O43614 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ PTGDR Q13258 1/20 0.34
▸ PTGDR2 Q9Y5Y4 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ SLC6A2 P23975 3/20 0.33
▸ SLC6A4 P31645 3/20 0.33
▸ SLC6A3 Q01959 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17303503 0.89 HTR2C (0.44) HTR2CHTR2AHTR2BNPY5RPKM
SCHEMBL17304011 0.84 CTSB (0.43) HTR2CHTR2BNPY5RKMT2APTGDR2
SCHEMBL18672679 0.84 NPY5R (0.38) HTR2CHTR2AHTR2BNPY5RKMT2A
SCHEMBL19287742 0.82 SLC6A2 (0.39) HTR2CHTR2AHTR2BNPY5RSLC6A2
SCHEMBL17303823 0.81 HTR2C (0.53) HTR2CHTR2AHTR2BNPY5RHCRTR2
SCHEMBL25896899 0.80 HTR2C (0.46) HTR2CHTR2AHTR2BNPY5RKMT2A
SCHEMBL17303999 0.78 HTR2A (0.60) HTR2CHTR2ANPY5RPTGDRPTGDR2
SCHEMBL15830332 0.78 HTR2A (0.60) HTR2CHTR2ANPY5RPTGDRPTGDR2
SCHEMBL17303825 0.78 HTR2A (0.60) HTR2CHTR2ANPY5RPTGDRPTGDR2
SCHEMBL17300864 0.74 USP30 (0.43) HTR2CHTR2AHTR2BNPY5RSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170334861-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2017-11-23 — — US disclosed
US-9745291-B2 PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof Epizyme, Inc. (US) 2017-08-29 — — US disclosed
US-20170210751-A1 PRMT5 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334861-A1 TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT3 HTR2C 3973/4885HTR2A 3996/4885HTR2B 3820/4885
US-20170210751-A1 PRMT5 INHIBITORS AND USES THEREOF PRMT5, PRMT1, PRMT6 HTR2C 4296/4885HTR2A 4251/4885HTR2B 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback